SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
16 references·1 citing·31 second hop
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response (2022)Serotonin 5-HT2A, 5-HT2c and 5-HT1A recep…Increased global integration in the brain after psilocybin therapy for depression (2022)Increased global integration …Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Psilocybin induces rapid and …Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice (2021)Harnessing psilocybin: antide…The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects (2020)The Subjective Effects of Psy…Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Effects of Psilocybin-Assiste…A non-hallucinogenic psychedelic analogue with therapeutic potential (2020)A non-hallucinogenic psychede…Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (2019)Psychedelic effects of psiloc…Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Classic psychedelics: An inte…Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens (2016)Receptor interaction profiles…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Multiple receptors contribute…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice (2022)Structure–Activity Relationsh…Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Psychedelics and the essential importance of context (2018)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. (1998)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies (2020)Psychedelics reopen the social reward learning critical period (2023)A RATING SCALE FOR DEPRESSION (1960)Manual for the State-Trait Anxiety Inventory (1970)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial (2022)Psychedelics promote plasticity by directly binding to BDNF receptor TrkB (2023)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors (2023)
this work references cited by second hop

References

  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2020Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder1,296 cited
  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2021Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo622 cited
  • 2020The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects538 cited
  • 2019Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels513 cited
  • 2018Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function506 cited
  • 2020A non-hallucinogenic psychedelic analogue with therapeutic potential468 cited
  • 2022Increased global integration in the brain after psilocybin therapy for depression441 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
411 cited
  • 2021Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice378 cited
  • 2016Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens377 cited
  • Cited by

    • 2022Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice91 cited